A breton lab entrusted us with a clinical evaluation of the effectiveness of its active ingredient – extracted from broccoli – in the treatment of prostate cancer.
Ouest France of the 21/09/2015
The results of the phase II study on Prostaphane® have been published.
Published on 12/05/2015 in the Cancer Prevention Research journal. The study was carried out in 14 centres in France on 78 patients with biological recurrence after total prostatectomy.